These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 32883070

  • 1. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG, Pan ZY, Zhang DY, Cao Q, Ji LN, Mao ZW.
    ACS Appl Mater Interfaces; 2020 Sep 30; 12(39):43444-43455. PubMed ID: 32883070
    [Abstract] [Full Text] [Related]

  • 2. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
    Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, Mu X.
    ACS Nano; 2024 Aug 13; 18(32):21156-21170. PubMed ID: 39088743
    [Abstract] [Full Text] [Related]

  • 3. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 4. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y, Deng Y, Tian X, Ke H, Guo M, Zhu A, Yang T, Guo Z, Ge Z, Yang X, Chen H.
    ACS Nano; 2015 Oct 27; 9(10):9626-37. PubMed ID: 26365698
    [Abstract] [Full Text] [Related]

  • 5. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
    Du C, Ding Y, Qian J, Zhang R, Dong CM.
    J Mater Chem B; 2019 Jan 21; 7(3):415-432. PubMed ID: 32254729
    [Abstract] [Full Text] [Related]

  • 6. A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR-Light-Triggered Hyperthermia.
    Wang L, Yu Y, Wei D, Zhang L, Zhang X, Zhang G, Ding D, Xiao H, Zhang D.
    Adv Mater; 2021 May 21; 33(20):e2100599. PubMed ID: 33834553
    [Abstract] [Full Text] [Related]

  • 7. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W, Jiang Y, Li Q, Zhang D, Li Z, Luan Y.
    Acta Biomater; 2019 Jan 15; 84():356-366. PubMed ID: 30502480
    [Abstract] [Full Text] [Related]

  • 8. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X, Wang Y, Chen Z, Wu Y, Chen H, Yang X, Yu C.
    Chem Commun (Camb); 2020 Sep 28; 56(76):11271-11274. PubMed ID: 32830841
    [Abstract] [Full Text] [Related]

  • 9. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
    Pathak RK, Wen R, Kolishetti N, Dhar S.
    Mol Cancer Ther; 2017 Apr 28; 16(4):625-636. PubMed ID: 28148716
    [Abstract] [Full Text] [Related]

  • 10. A conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma.
    Wang X, Chang Z, Nie X, Li Y, Hu Z, Ma J, Wang W, Song T, Zhou P, Wang H, Yuan Z.
    Nanomedicine; 2019 Jan 28; 15(1):153-163. PubMed ID: 30308299
    [Abstract] [Full Text] [Related]

  • 11. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F, Sun T, Xu Z, Wang Z, Kong W, To MW, Wang F, Zhu G.
    Dalton Trans; 2016 Aug 16; 45(33):13052-60. PubMed ID: 27430044
    [Abstract] [Full Text] [Related]

  • 12. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
    Wang Z, Xu Z, Zhu G.
    Angew Chem Int Ed Engl; 2016 Dec 12; 55(50):15564-15568. PubMed ID: 27736029
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y, Liu G, Ma J, Lin J, Lin H, Su G, Chen D, Ye S, Chen X, Zhu X, Hou Z.
    J Control Release; 2017 Jul 28; 258():95-107. PubMed ID: 28501673
    [Abstract] [Full Text] [Related]

  • 14. Dual-Stimuli-Responsive Multifunctional Gd2Hf2O7 Nanoparticles for MRI-Guided Combined Chemo-/Photothermal-/Radiotherapy of Resistant Tumors.
    Kuang Y, Zhang Y, Zhao Y, Cao Y, Zhang Y, Chong Y, Pei R.
    ACS Appl Mater Interfaces; 2020 Aug 12; 12(32):35928-35939. PubMed ID: 32686939
    [Abstract] [Full Text] [Related]

  • 15. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
    Cao ZT, Chen ZY, Sun CY, Li HJ, Wang HX, Cheng QQ, Zuo ZQ, Wang JL, Liu YZ, Wang YC, Wang J.
    Biomaterials; 2016 Jul 12; 94():9-19. PubMed ID: 27088406
    [Abstract] [Full Text] [Related]

  • 16. NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy.
    Liu XM, Zhu ZZ, He XR, Zou YH, Chen Q, Wang XY, Liu HM, Qiao X, Wang X, Xu JY.
    ACS Appl Mater Interfaces; 2024 Aug 07; 16(31):40753-40766. PubMed ID: 39046129
    [Abstract] [Full Text] [Related]

  • 17. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR.
    Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446
    [Abstract] [Full Text] [Related]

  • 18. Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles.
    Zhang C, Zhao X, Guo H.
    Artif Cells Nanomed Biotechnol; 2018 Jun 23; 46(sup2):356-363. PubMed ID: 29607699
    [Abstract] [Full Text] [Related]

  • 19. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance.
    Ma J, Li L, Yue K, Li Y, Liu H, Wang PG, Wang C, Wang J, Luo W, Xie S.
    Bioorg Chem; 2020 Jun 23; 99():103768. PubMed ID: 32217375
    [Abstract] [Full Text] [Related]

  • 20. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R, Zhang Z, Wang B, Chen G, Zhang Y, Deng H, Tang Z, Mao J, Wang L.
    Drug Des Devel Ther; 2020 Jun 23; 14():2249-2261. PubMed ID: 32606595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.